Skin allergies (atopic dermatitis) affect millions of dogs and cause chronic itch and discomfort. Modern treatment options have significantly improved welfare outcomes.
Canine atopic dermatitis causes chronic suffering through unrelenting itch that significantly reduces quality of life. Affected dogs scratch, rub, and lick constantly, disrupting sleep, social interaction, and normal behaviour. Secondary skin infections cause additional pain and discomfort. The welfare impact compounds over months and years of inadequately treated disease. Modern treatment has transformed the outlook for atopic dogs — targeted itch-control medications including dupilumab analogs, oclacitinib, and lokivetmab provide rapid, effective relief with good safety profiles. The challenge is ensuring owners seek and maintain appropriate veterinary treatment rather than relying on ineffective over-the-counter products. Allergen-specific immunotherapy offers the possibility of long-term disease modification for suitable cases.